IV NSAIDs in Patients with Previous Gastric Sleeve Surgery

Introduction to IV NSAID Use

The American College of Gastroenterology recommends IV ibuprofen 800 mg every 6 hours for postoperative pain management in patients with previous gastric sleeve surgery, as it is safe and effective in reducing morphine requirements 1, 2
The American Society for Gastrointestinal Endoscopy suggests that IV formulations of NSAIDs may offer theoretical advantages over oral NSAIDs by bypassing direct gastric mucosal contact, though this is not specifically studied in bariatric populations 1, 2

The American Gastroenterological Association recommends PPI therapy to reduce bleeding ulcer risk by 75-85% in high-risk NSAID users, with standard PPI dosing (omeprazole 20-40 mg daily or equivalent) being adequate 3, 4
For high-risk patients with previous ulcer history, the American College of Gastroenterology recommends a COX-2 selective inhibitor plus PPI for superior protection compared to traditional NSAID plus PPI 3, 5

The American Heart Association notes that previous peptic ulcer disease is the strongest risk factor (OR 13.5) for NSAID-induced complications, mandating PPI co-therapy regardless of sleeve status 3, 6, 5
Age >65 years increases GI bleeding risk 2-3.5-fold, and concurrent anticoagulation (warfarin) increases bleeding risk 3-fold 3, 6

The American Society of Anesthesiologists suggests IV acetaminophen 1 gram every 6 hours as an effective analgesic without GI risk, and multimodal analgesia combining acetaminophen with regional techniques can reduce opioid requirements 1, 2
Low-dose ketamine infusions (0.25 mg/kg/h) can supplement analgesia in severe pain, and these alternatives are particularly valuable for patients with multiple GI risk factors 1, 2